Video: Investor Calls for Workforce Development to Strengthen Blood Plasma Ecosystem
CNBC Indonesia held the CNBC Indonesia Health Summit 2026 on Thursday, 8 October 2026, under the theme “The Rising of Indonesia’s Healthcare Investment”. The event examined the direction and future of healthcare investment in Indonesia as a means of strengthening health resilience and supporting the national economy.
Andreas Gutknecht, president director of PT Takeda Life Sciences, outlined the objectives and investment commitment of Takeda Life Sciences, which is investing up to US$30 billion in developing Indonesia’s plasma-derived medicinal products (PDMP) ecosystem. These are medicines made from blood plasma.
The sustainable strengthening of the blood plasma ecosystem is intended to improve public health by ensuring supplies of plasma-based medicines.
Gutknecht discussed the urgency of developing Indonesia’s plasma ecosystem, as well as the challenges and investment prospects, during a dialogue titled “Pharmaceutical and Medical Device Innovation for Strengthening Public Health Resilience” at the CNBC Indonesia Health Summit 2026 on Thursday, 8 October 2026.
Source: jawawa.id (https://jawawa.id/newsitem/video-investor-calls-for-workforce-development-to-strengthen-blood-plasma-ecosystem-1792140758)
Originally published by CNBC Indonesia (https://www.cnbcindonesia.com/lifestyle/20261016122819-35-776823/video-perkuat-ekosistem-plasma-darah-investor-dorong-penguatan-sdm), translated from Indonesian